In this podcast, Dr. Xiuning Le discusses research from the 2022 North America Conference on Lung Cancer, including 3 studies evaluating targeted therapy treatments for people with non-small cell lung cancer.
Drs. David Ilson, Sumanta (Monty) Pal, and Tian Zhang discuss new research presented at the 2022 ESMO Congress, including studies about treating liver, colorectal, stomach, kidney, bladder, and prostate cancers.
What Are Multi-Cancer Early Detection Tests and How Might They Impact the Future of Cancer Screening?
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses what multi-cancer early detection tests are, the ongoing research being done around them, and their potential use as a future tool for multi-cancer screening.
In this podcast, Dr. Manali Patel interviews Stephanie Walker about her experience living with metastatic breast cancer, how she got involved with patient advocacy, and her work leading the BECOME Research project to increase Black patient participation in clinical trials.
Effects of Patient Navigation, Lower-Cost Drug Alternatives on the Cost of Cancer Care and Rates of Metastatic Cancer Diagnoses and Deaths After Medicaid Expansion: Research from the 2022 ASCO Quality Care Symposium
Read research from the 2022 ASCO Quality Care Symposium, including studies on how cancer navigation programs and lower-cost drug alternatives can lower the cost of care and a study on how Medicaid expansion affected the rates of metastatic cancer diagnoses and cancer deaths.
2022 ASCO Annual Meeting Research Round Up: New Research in Lung Cancer, Lymphoma, and Childhood Cancers
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in non-small cell lung cancer, non-Hodgkin lymphoma, Ewing sarcoma, and neuroblastoma.
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses the importance of World Cancer Research Day, which takes place each year on September 24, and the progress made in cancer care as a result of research being conducted around the world.
2022 ASCO Annual Meeting Research Round Up: New Research in Head and Neck Cancer, Brain Tumors, and Health Equity
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in head and neck cancer, brain tumors, and health equity.
Read research from the August 2022 session of the ASCO Plenary Series, which features a study that evaluated how common it is for people with lung cancer to have inherited genetic mutations known to increase cancer risk.
In this post, several experts describe the importance of peer-reviewed cancer information, including what “peer reviewed” means, what to know about levels of scientific evidence in cancer research, and the differences between research done in cell lines, animals, and humans.